Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia.
JAMA Otolaryngol Head Neck Surg. 2023 Mar 1;149(3):204-211. doi: 10.1001/jamaoto.2022.4466.
Although more than 200 genes have been associated with monogenic congenital hearing loss, the polygenic contribution to hearing decline across the life course remains largely unknown.
To examine the association of polygenic risk scores (PRSs) for self-reported hearing difficulty among adults (40-69 years) with measured hearing and speech reception abilities in mid-childhood and early midlife.
DESIGN, SETTING, AND PARTICIPANTS: This was a population-based cross-sectional study nested within the Longitudinal Study of Australian Children that included 1608 children and 1642 adults. Pure tone audiometry, speech reception threshold against noise, and genetic data were evaluated. Linear and logistic regressions of PRSs were conducted for hearing outcomes. Study analysis was performed from March 1 to 31, 2022.
Genotypes were generated from saliva or blood using global single-nucleotide polymorphisms array and PRSs derived from published genome-wide association studies of self-reported hearing difficulty (PRS1) and hearing aid use (PRS2). Hearing outcomes were continuous using the high Fletcher index (mean hearing threshold, 1, 2, and 4 kHz) and speech reception threshold (SRT); and dichotomized for bilateral hearing loss of more than 15 dB HL and abnormal SRT.
Included in the study were 1608 children (mean [SD] age, 11.5 [0.5] years; 812 [50.5%] male children; 1365 [84.9%] European and 243[15.1%] non-European) and 1642 adults (mean [SD] age, 43.7 [5.1] years; 1442 [87.8%] female adults; 1430 [87.1%] European and 212 [12.9%] non-European individuals). In adults, both PRS1 and PRS2 were associated with hearing thresholds. For each SD increment in PRS1 and PRS2, hearing thresholds were 0.4 (95% CI, 0-0.8) decibel hearing level (dB HL) and 0.9 (95% CI, 0.5-1.2) dB HL higher on the high Fletcher index, respectively. Each SD increment in PRS increased the odds of adult hearing loss of more than 15 dB HL by 10% to 30% (OR for PRS1, 1.1; 95% CI, 1.0-1.3; OR for PRS2, 1.3; 95% CI, 1.1-1.5). Similar but attenuated patterns were noted in children (OR for PRS1, 1.1; 95% CI, 0.8-1.2; OR for PRS2, 1.2; 95% CI, 1.0-1.5). Both PRSs showed minimal evidence of associations with speech reception thresholds or abnormal SRT in children or adults.
This population-based cross-sectional study of PRSs for self-reported hearing difficulty among adults found an association with hearing ability in mid-childhood. This adds to the evidence that age-related hearing loss begins as early as the first decade of life and that polygenic inheritance may play a role together with other environmental risk factors.
尽管已有 200 多个基因与单基因先天性听力损失相关,但多基因对整个生命过程中的听力下降的贡献在很大程度上仍不清楚。
研究成年人(40-69 岁)报告的听力困难的多基因风险评分(PRS)与儿童中期和中年早期测量的听力和言语接受能力之间的关联。
设计、设置和参与者:这是一项基于人群的横断面研究,嵌套在澳大利亚儿童纵向研究中,包括 1608 名儿童和 1642 名成年人。评估了纯音测听、言语接受阈对抗噪声和遗传数据。对 PRS 进行了听力结果的线性和逻辑回归分析。研究分析于 2022 年 3 月 1 日至 31 日进行。
使用全球单核苷酸多态性芯片从唾液或血液中生成基因型,并从已发表的自我报告听力困难(PRS1)和助听器使用(PRS2)的全基因组关联研究中得出 PRS。听力结果使用高 Fletcher 指数(平均听力阈值,1、2 和 4 kHz)和言语接受阈值(SRT)连续表示;并将双侧听力损失超过 15 dB HL 和异常 SRT 进行二分类。
研究包括 1608 名儿童(平均[标准差]年龄,11.5[0.5]岁;812[50.5%]男童;1365[84.9%]欧洲人和 243[15.1%]非欧洲人)和 1642 名成年人(平均[标准差]年龄,43.7[5.1]岁;1442[87.8%]女性成年人;1430[87.1%]欧洲人和 212[12.9%]非欧洲人)。在成年人中,PRS1 和 PRS2 均与听力阈值相关。PRS1 和 PRS2 每增加一个标准差,高 Fletcher 指数上的听力阈值分别增加 0.4(95%CI,0-0.8)分贝(dB)和 0.9(95%CI,0.5-1.2)dB。PRS 每增加一个标准差,成年人听力损失超过 15 dB HL 的几率增加 10%至 30%(PRS1 的 OR,1.1;95%CI,1.0-1.3;PRS2 的 OR,1.3;95%CI,1.1-1.5)。在儿童中也观察到类似但减弱的模式(PRS1 的 OR,1.1;95%CI,0.8-1.2;PRS2 的 OR,1.2;95%CI,1.0-1.5)。在儿童或成年人中,PRS 与言语接受阈值或异常 SRT 几乎没有关联。
本项基于人群的横断面研究发现,成年人自我报告的听力困难的 PRS 与儿童中期的听力能力相关。这进一步证明了年龄相关性听力损失早在生命的第一个十年就开始了,多基因遗传可能与其他环境风险因素一起发挥作用。